Cargando…

P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes

BACKGROUND: Randomized trials have shown superiority of the novel P2Y12 inhibitors over clopidogrel in patients with acute coronary syndrome (ACS), but clinical benefit in the community remains controversial. Our objective was to compare the safety and efficacy of clopidogrel to ticagrelor and prasu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sachdeva, Amit, Mutyala, Ratnabhushan, Mantri, Neha, Zhu, Shiyun, McNulty, Edward, Solomon, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224789/ https://www.ncbi.nlm.nih.gov/pubmed/37251366 http://dx.doi.org/10.1155/2023/1147352

Ejemplares similares

Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis
por: Lee, Yonggu, et al.
Publicado: (2020)

Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks
por: Spertus, John A, et al.
Publicado: (2015)

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019)

Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
por: Rohla, Miklos, et al.
Publicado: (2016)

Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention
por: Kumar, Arun, et al.
Publicado: (2022)

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
por: Grosdidier, Charlotte, et al.
Publicado: (2019)

Real‐world use of idarucizumab for dabigatran reversal in three cases of serious bleeding
por: Gendron, Nicolas, et al.
Publicado: (2017)

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2021)

Real-World Data on Potent P2Y12 Inhibition in Patients with Suspected Chronic Coronary Syndrome, Referred for Coronary Angiography
por: Träff, Erik, et al.
Publicado: (2022)

Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions
por: Doomun, Daphné, et al.
Publicado: (2021)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients
por: Al‐Hamed, Faez Saleh, et al.
Publicado: (2021)

Real-World Evidence: A Primer
por: Dang, Amit
Publicado: (2023)

Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve Replacement
por: Carmona, Adrien, et al.
Publicado: (2020)

Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention
por: Kim, Hangyul, et al.
Publicado: (2023)

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience
por: Agarwal, Amit, et al.
Publicado: (2021)

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
por: Anghel, Larisa, et al.
Publicado: (2020)

Thrombin Is an Effective and Safe Therapy in the Management of Bleeding Gastric Varices. A Real-World Experience
por: Gillespie, Sarah-Louise, et al.
Publicado: (2021)

Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022)

Detection of Major Cardioembolic Sources in Real-World Patients with Ischemic Stroke or Transient Ischemic Attack of Undetermined Cause
por: van der Maten, Gerlinde, et al.
Publicado: (2021)

Real world evidence: An Indian perspective
por: Dang, Amit, et al.
Publicado: (2016)

Comparison of cholinesterase inhibitor safety in real-world practice
por: Carney, Greg, et al.
Publicado: (2019)

Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor
por: ten Haaf, Monique E., et al.
Publicado: (2023)

Ischemic and Bleeding Events Associated with Thrombocytopenia and Thrombocytosis after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2020)

Prognosis of Claims‐ Versus Trial‐Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting
por: Butala, Neel M., et al.
Publicado: (2021)

Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Shi, Boqun, et al.
Publicado: (2023)

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting
por: Ay, Cihan, et al.
Publicado: (2020)

Establishment of a model for predicting delayed post-polypectomy bleeding: A real-world retrospective study
por: Lu, Yu, et al.
Publicado: (2022)

The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)

Coronavirus Associated Bleeding Esophageal Ulcerations
por: Sachdeva, Karan, et al.
Publicado: (2022)

Verifynow P2Y(12) PRU-Guided Modification of Clopidogrel for Prevention of Recurrent Ischemic Stroke: A Real-World Prospective Cohort Study
por: Zhang, Yuanjin, et al.
Publicado: (2022)

Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries
por: Williams, James M., et al.
Publicado: (2023)

Improvements in Coronary Stent Design Translate to Better Real-World Outcomes
por: Butala, Neel M., et al.
Publicado: (2021)

Multivessel Coronary Disease and Severe Atherosclerotic Aorta: Real-World Experience
por: Gasparovic, Ivo, et al.
Publicado: (2023)

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
por: Zhang, Shijia, et al.
Publicado: (2021)

Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke
por: Gao, Lan, et al.
Publicado: (2021)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Predictive model of recurrent ischemic stroke: model development from real-world data
por: Elhefnawy, Marwa Elsaeed, et al.
Publicado: (2023)

Bleeding risk stratification in coronary artery surgery: the should-not-bleed score
por: Petricevic, Mirna, et al.
Publicado: (2021)

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
por: Kapoor, Akhil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gssbc90oje8k2gvqvsql73ecc1